PKM and neoplasm: RNA m7G modification plays a pivotal role in tumor development, and METTL1 has been shown to mediate m7G modification of PKM2 mRNA, enhancing its translation and upregulating PKM2 protein levels, thereby promoting tumor progression and glycolytic activity (19).